21.09.2016
| . | . | |||
| LDG() | 449,7 | / | 226-451 | . |
| TP( ) | 74,0 | / | 64-87 | . |
| GL() | 3,7 | / | 4-6,1 | |
| UREA() | 2,21 | / | 1,7-8,3 | . |
| 83,2 | / | 61-115 | . | |
| ALT() | 28,4 | / | 0-40 | . |
| AST() | 23,2 | / | 0-37 | . |
| GGT() | 44,4 | / | 11-61 | . |
| CHOL() | 4,86 | / | 3,24-5,17 | . |
| TR() | 1,02 | / | 0-1,7 | . |
: . .
.
14.09.2016
:
. (). . . , , . , . , . , . .
: : ( ).
21.09.2016
, -60 /, 120/80 ...
: , . , , ( ). . , , , 16 2, / 69%, vena contracta 6,8 ; MR ERO 0,46 2; MR Volume 98 ml.
35 .
: . , , . .
: . . : 27 ... : 37 ...
: . 47 54 ; 92 . . . - 48 / (N> 20 /)
: . 40 55;
:
: - . . : , . . . . .
|
|
|
:
16.09.2016
| 1 | %(1/) | 2 | %(2/) | %(2/1) | %(2-1/1) | ||
| VC MAX | 3.56 | 3.92 | 110.08% | 4.09 | 114.85% | 104.34% | 6.36 |
| IC | 2.56 | ||||||
| ERV | 1.00 | ||||||
| FVC | 3.44 | 3.88 | 112.57% | 4.09 | 118.84% | 105.57% | 9.97 |
| FEV1 | 2.71 | 2.95 | 108.92% | 3.00 | 110.78% | 101.71% | 2.72 |
| FEV1%F | 76.06 | 73.27 | 96.34% | 3.66 | |||
| FEV1%M | 75.69 | 75.17 | 99.31% | 73.27 | 96.81% | 97.48% | 2.52 |
| PEF | 7.47 | 6.37 | 85.33% | 7.85 | 106.16% | 123.23% | 23.28 |
| MMEF | 3.13 | 2.32 | 74.20% | 2.16 | 69.16% | 93.25% | 6.68 |
| MEF 75 | 6.63 | 4.89 | 73.80% | 5.43 | 81.90% | 110.98% | 11.38 |
| MEF 50 | 3.88 | 2.78 | 71.51% | 2.66 | 68.61% | 96.96% | 4.14 |
| MEF 25 | 1.28 | 1.05 | 82.18% | 0.85 | 66.59% | 81.08% | 10.47 |
| FET | 4.69 | 5.39 | 116.00% | 14.06 | |||
| FETREF | 0.07 | 0.06 | 88.92% | 10.08 |
: . . (400 ) .
26.09.2016
/ - 0,25%-20,0 . , , , , , . , , : : , ; 40-50%, ( 2,0 ) 80-90%, 1,0 ; , , . . : , , . , , . . . ..
:
. . 40-50%. ( 2,0 ) 80-90%( 1,0 ). .
:
:
26.09.2016
: . , , . : 1-2 60 / 1 \ , - 2 .
